White Harvey D, Palmeri Sebastian T, Sleeper Lynn A, French John K, Wong Cheuk-Kit, Lowe April M, Crapo Julia W, Koller Patrick T, Baran Kenneth W, Boland Jean L, Hochman Judith S, Wagner Galen S
Cardiovascular Research Unit, Green Lane Hospital, Auckland, New Zealand.
Am Heart J. 2004 Nov;148(5):810-7. doi: 10.1016/j.ahj.2004.05.012.
To evaluate electrocardiographic (ECG) parameters as predictors of 1-year mortality in patients developing cardiogenic shock after acute myocardial infarction (AMI), and to document associations between these ECG parameters and the survival benefit of emergency revascularization versus initial medical stabilization.
Emergency revascularization reduces the risk of mortality in patients developing cardiogenic shock after AMI. The prognostic value of ECG parameters in such patients is unclear, and it is uncertain whether emergency revascularization reduces the mortality risk denoted by ECG parameters.
In a prospective substudy of 198 SHOCK (SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK) trial patients, ECGs recorded within 12 hours of shock were interpreted by personnel blinded to the patients' treatment assignment and outcome.
The baseline heart rate was higher in non-survivors than in survivors (106 +/- 20 versus 95 +/- 24 beats/minute, P = .001). There was a significant association between the QRS duration and 1-year mortality in medically stabilized patients (115 +/- 28 ms in non-survivors versus 99 +/- 23 ms in survivors, P = .012), but not in emergently revascularized patients (110 +/- 31 versus 116 +/- 27 ms respectively, P = .343). The interaction between the QRS duration, mortality and treatment assignment was significant (P = .009). Among patients with inferior AMI, a greater sum of ST depression was associated with higher 1-year mortality in medically stabilized patients (P = .029), but not in emergently revascularized patients (P = .613, treatment interaction P = .025). On multivariate analysis, the independent mortality predictors were increasing age, elevated pulmonary capillary wedge pressure, heart rate, sum of ST depression in medically stabilized patients, and interaction (P = .016) between a prolonged QRS duration and treatment assignment. The adjusted hazard ratio for 1-year mortality per 20 ms increase in the QRS duration was 1.19 (95% CI 0.98-1.46) in medically stabilized patients and 0.81 (95% CI 0.63-1.03) in emergently revascularized patients.
ECG parameters identified patients with cardiogenic shock who were at high risk. Emergency revascularization eliminated the incremental mortality risk associated with cardiogenic shock in patients with a prolonged QRS duration, or inferior AMI accompanied by precordial ST depression. Prospective assessments of the magnitude of the treatment effect based on ECG parameters are required.
评估心电图(ECG)参数作为急性心肌梗死(AMI)后发生心源性休克患者1年死亡率的预测指标,并记录这些ECG参数与紧急血运重建与初始药物稳定治疗的生存获益之间的关联。
紧急血运重建可降低AMI后发生心源性休克患者的死亡风险。此类患者中ECG参数的预后价值尚不清楚,且紧急血运重建是否能降低由ECG参数所提示的死亡风险也不确定。
在一项对198例SHOCK(急性心肌梗死并发心源性休克患者是否应紧急行闭塞冠状动脉血运重建术)试验患者的前瞻性子研究中,由对患者治疗分配和结局不知情的人员解读休克12小时内记录的ECG。
非存活者的基线心率高于存活者(106±20对95±24次/分钟,P = .001)。在接受药物稳定治疗的患者中,QRS时限与1年死亡率之间存在显著关联(非存活者为115±28毫秒,存活者为99±23毫秒,P = .012),但在接受紧急血运重建治疗的患者中无此关联(分别为110±31与116±27毫秒,P = .343)。QRS时限、死亡率和治疗分配之间的交互作用显著(P = .009)。在下壁AMI患者中,ST段压低总和越大,在接受药物稳定治疗的患者中1年死亡率越高(P = .029),但在接受紧急血运重建治疗的患者中并非如此(P = .613,治疗交互作用P = .025)。多因素分析显示,独立的死亡预测因素为年龄增加、肺毛细血管楔压升高、心率、接受药物稳定治疗患者的ST段压低总和,以及QRS时限延长与治疗分配之间的交互作用(P = .016)。在接受药物稳定治疗的患者中,QRS时限每增加20毫秒,1年死亡率的调整后风险比为1.19(95%CI 0.98 - 1.46),在接受紧急血运重建治疗的患者中为0.81(95%CI 0.63 - 1.03)。
ECG参数可识别出发生心源性休克的高危患者。紧急血运重建消除了QRS时限延长或下壁AMI伴胸前导联ST段压低患者中心源性休克相关的额外死亡风险。需要基于ECG参数对治疗效果的大小进行前瞻性评估。